Search

Your search keyword '"Clobazam"' showing total 2,492 results

Search Constraints

Start Over You searched for: Descriptor "Clobazam" Remove constraint Descriptor: "Clobazam"
2,492 results on '"Clobazam"'

Search Results

3. Utilizing an acute hyperthermia‐induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome.

4. Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program.

5. Spectrophotometric quantification of trace levels of cyanide in water-insoluble drug substances and confirmation of specificity through an orthogonal comparison approach.

6. Sindromul Dravet-caz clinic.

7. Impact of Age and Concurrent Antiseizure Medication Use on Lacosamide Dose to Concentration Ratio and Dosing in Pediatric Patients.

8. Advancements in Dravet Syndrome Therapeutics: A Comprehensive Look at Present and Future Treatment Horizons: A Focused Review.

9. Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy.

10. Prophylactic antiseizure medications for recurrent status epilepticus in nonsyndromic childhood epilepsy.

12. Advances in the Adjunctive Treatment of Lennox-Gastaut Syndrome with Clobazam and Cannabidiol

13. A computational clinical decision-supporting system to suggest effective anti-epileptic drugs for pediatric epilepsy patients based on deep learning models using patient's medical history.

14. Evaluation of potential drug–drug interactions with medical cannabis.

15. Long‐term benzodiazepine usage and mortality in patients with chronic non‐cancer musculoskeletal pain: A Nationwide cohort study.

17. Cerebral folate deficiency: a treatable cause of late deterioration in epilepsy with developmental delay.

18. Corticosteroids versus clobazam for treatment of children with epileptic encephalopathy with spike-wave activation in sleep (RESCUE ESES): a multicentre randomised controlled trial.

19. Inconsolability in a Nonverbal Adolescent.

20. Final analysis of potential drug–drug interactions between highly purified cannabidiol and anti‐seizure medications in an open‐label expanded access program.

23. Mutation in the GRIA4 Gene Presenting as ESES: Expanding the Genetic Landscape of ESES.

24. NAVIGATING TUBEROUS SCLEROSIS IN A 41-YEAROLD PATIENT: CLINICAL INSIGHTS AND MANAGEMENT.

25. Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study

26. A Case of Metabolic Encephalopathy Due to Recurrent Hypoglycemia Caused by Insulin: A Case Report.

27. Management of epilepsy with eyelid myoclonia: Results of an international expert consensus panel.

32. Development of a robust UPLC-MS/MS method for the quantification of riluzole in human plasma and its application in pharmacokinetics.

33. Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy.

34. Development and validation of a liquid chromatography–tandem mass spectrometry method of a panel of commonly prescribed benzodiazepines in urine samples.

35. Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome.

36. Treatment of drop attacks: Anti-seizure drug choices of pediatric neurologists in Saudi Arabia.

37. Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study.

38. Expert Consensus on Clobazam in the Treatment of Refractory Epilepsy (2022)

40. A retrospective non‐interventional study evaluating the pharmacokinetic interactions between cenobamate and clobazam.

41. Psychiatric Approach in Phantom Erection Postpenectomy Patient.

42. Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant epilepsies: Four‐year results from the expanded access program.

43. EU Contract Notice: GWQ ServicePlus AG Issues contract notice|solicitation for 'Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V with the active ingredient Clobazam'

47. Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations.

48. Retrospective analysis of metabolite patterns of clobazam and N-desmethylclobazam in human plasma by LC-MS/MS

49. Efficacy and safety of phenytoin versus clobazam as monotherapy for newly diagnosed epileptic patients

50. Addition of clobazam successfully treating drug resistant seizures in Heidenhain variant Creutzfeldt Jakob disease: A case report

Catalog

Books, media, physical & digital resources